Regorafenib

Regorafenib is primarily used to treat advanced colorectal cancer and gastrointestinal stromal tumors (GISTs) that have not responded to other treatments. It belongs to a class of medications known as kinase inhibitors, working by slowing down or stopping the growth of cancer cells.